Cancer Drug Resistance
@cdrjournal
Followers
867
Following
976
Media
1K
Statuses
2K
Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 Pharmacology(medical). Indexed in PubMed Central(PMC), ESCI and Scopus #Cancer #DrugResistance
Beijing, China
Joined September 2020
🎉 CDR Impact Factor hits 5.2! Now ranked Q1 in Oncology (64/326) ⬆️ Up 13% from last year (4.6) Proud to be the only journal focused on cancer drug resistance. Huge thanks to our contributors and our amazing Editorial Board!👏 🔗More details here: https://t.co/4Q2M7xTNNC
0
3
10
👉New publish in #Cancer #DrugResistance! ✍️Mechanisms of resistance to antibody-drug #conjugates in cancer therapy: #molecular basis and therapeutic strategies 👏Antibody-drug conjugates, resistance, mechanism, challenges, future directions 🙌Read: https://t.co/7W0XeuYYQq
0
0
0
👏New Interview Alert! @weldeiry 👉We are thrilled to share our latest interview with Prof. Wafik S. El-Deiry! Prof. El-Deiry explores the potential role of cutting-edge technologies in overcoming #Cancer #DrugResistance. 👀More: https://t.co/1Oxjismxzg
0
4
6
👉Publish in #Cancer #DrugResistance! 🙌Title: #Reprogrammed lipid #metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 👏Metabolic signaling, therapy resistance, tumor microenvironment, metastasis, immune evasion 👀Read: https://t.co/SJtLTaA6A5
0
1
1
👏Publish in #Cancer #DrugResistance! ✍️Title: HDAC-driven mechanisms in #anticancer resistance: #epigenetics and beyond 👉Keywords HDACs, #chemotherapy, hormone deprivation, acetylation, #palbociclib, #PARP, DNA damage 👀Read: https://t.co/CrV7gWC9Hv
0
1
1
✍️Publish in #Cancer #DrugResistance! 👀Tltle: Mechanism of #ferroptosis resistance in cancer cells 🌟Key words: Ferroptosis resistance, lipid peroxidation, #iron, cancer, antioxidant defenses 👏Read: https://t.co/Ii4XID4lHi
0
0
1
📢Publish in #Cancer #DrugResistance about #BreastCancer! ✍️Title: Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axis 📚Read: https://t.co/i0rPYba3f5
0
1
1
✍️New publish in #Cancer #DrugResistance! 🙌Title: RCC1 knockdown sensitizes drug-resistant #colorectal cancer to 5-fluorouracil or #doxorubicin by impairing DNA repair 👉Read: https://t.co/8poHA7tl0f
0
1
1
🙌New publish in #Cancer #DrugResistance about #NSCLC! 👉Key words: Focal adhesion kinase (FAK), EGFR-TKI resistance, non-small cell lung cancer (NSCLC), #Afatinib, #Osimertinib 👏Read: https://t.co/7EL3xN2IFM
0
0
0
👏We are thrilled to welcome Prof. Nadia M. Hamdy from Ain Shams University to the Editorial Board Member of #Cancer #DrugResistance! 🎉Her expertise in biochemistry, molecular biology, and cancer research will be a great asset to CDR. 👉More: https://t.co/49BKmo2giR
0
1
1
🌟Call for Papers for Special Issue！ 👉Topic: Mechanisms of Resistance in Solid Tumors and Precision Medicine Approaches 👨💼Guest editor: @Prof_HengruiLiu 👀Contact: Lori@cancerdrugresist.com 🙌Read more: https://t.co/cKg8kYRkZB
0
1
1
🌟Publish in #Cancer #DrugResistance! 🔦Title: Overcoming drug resistance through extracellular vesicle-based drug delivery system in cancer treatment 📚Read: https://t.co/KHRHqI6vX7
0
1
2
✍️Publish in #Cancer #DrugResiatance about soft tissue Sarcoma! 🙌Title: CIRCUS: CIRCUlating tumour cells in soft tissue Sarcoma - a short report 🌟Circulating tumour cells, soft tissue sarcoma, #metastasis 👀Read: https://t.co/rBj88UDeG0
0
1
1
🙌New publish in #Cancer #DrugResistance! 👉Title: Circular #RNA-based liquid biopsy: a promising approach for monitoring drug resistance in cancer 👋Read: https://t.co/VDqgbTLVby
1
1
1
🙌New publish in #Cancer #DrugResistance! 👉Title: Targeting #tumor-draining lymph node to overcome resistance to cancer #immunotherapy: an update 👀Read more: https://t.co/MtBDab5RlT
0
0
0
🙌Publish in #Cancer #DrugResistance about #NSCLC! 👉Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer ✍️Lung cancer, tumor microenvironment, immune checkpoint blockade, resistance, mechanism 👀 https://t.co/QCJSGTrDLf
0
0
0
👉New publish in #Cancer #DrugResistance! 🙌Title: Recent progress on tyrosine kinase #inhibitors resistance in renal cell carcinoma: another brick in the wall? 👀Read more: https://t.co/xQZJ2VlED7 📩Download: https://t.co/CPo0oLOlU9
0
1
1
🙌Publish in #Cancer #DrugResistance about Ovarian tumor microenvironment! 👉Title: Ovarian tumor #microenvironment contributes to tumor progression and #chemoresistance 👀Read: https://t.co/tk1JPYkMvQ 📩Download: https://t.co/SOTNzeQxzV
0
2
2
👏Publish in #Cancer #DrugResistance！ ✍️Title: #Mitochondrial genome variability and metabolic alterations reveal new biomarkers of resistance in testicular germ cell tumors 👀Read more: https://t.co/bXJzBb64m3 📩Download: https://t.co/NW0QScOB87
0
1
1
🙌The new special topic is now accepting submissions! ✍️Key words: #UrologicalCancers; #DrugResistance 👉Guest Editors: @ Dr.William Cho; @DechaoF ; @UmberCheema; @UzoamakaOkoli2 ✉️Contacts: Lori@cancerdrugresist.com 👋Welcome submissions!
0
2
4
🙌New publish in #Cancer #DrugResistance on 10 Oct. 👉Title: KLF5 promotes tumor proliferation and #oxaliplatin resistance via chromatin remodeling in KRAS-mutated #ColorectalCancer. 👀Read more: https://t.co/ga4LhRchwl
0
1
1